Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 11 Jun 2022 - 17 Jun 2022
PAIN TYPE:Migraine/Headache
DATE PUBLISHED: 2022 Jun 13
JOURNAL:BMC Neurol
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/35698027?dopt=Abstract
Volume:22
ISSUE:1
OnabotulinumtoxinA has been widely used for control of chronic migraine. The aim of the current study was to evaluate the efficacy of different doses of the onabotulinumtoxinA therapy in patients with chronic migraine.